Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
Sphingosine-1-phosphate (S1P), via its G-protein-coupled receptors, is a signaling molecule with important regulatory properties on numerous, widely varied cell types. Five S1P receptors (S1PR1-5) have been identified, each with effects determined by their unique G-protein-driven downstream pathways...
Main Authors: | Stanley Cohan, Elisabeth Lucassen, Kyle Smoot, Justine Brink, Chiayi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/7/227 |
Similar Items
-
Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation
by: Alessandra Roggeri, et al.
Published: (2020-10-01) -
Acquired modification of sphingosine-1-phosphate lyase activity is not related to adrenal insufficiency
by: Gulin Sunter, et al.
Published: (2018-04-01) -
Roles of sphingosine-1-phosphate signaling in cancer
by: Peng Wang, et al.
Published: (2019-11-01) -
The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
by: Kana Masuda-Kuroki, et al.
Published: (2023-09-01) -
Risk for Cardiovascular Adverse Events Associated With Sphingosine-1-Phosphate Receptor Modulators in Patients With Multiple Sclerosis: Insights From a Pooled Analysis of 15 Randomised Controlled Trials
by: Zhao Zhao, et al.
Published: (2021-12-01)